VBLT

Vascular Biogenics News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Vascular Biogenics Ltd VBLT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.03 -1.46% 2.02 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.05 2.03 2.12 2.06 2.05
more quote information »

Recent News

Date Time Source Heading
5/04/202107:00GLOBEVBL Therapeutics to Report First Quarter Financial Results..
4/28/202110:39TRMNThese 2 Penny Stocks Could Rally Over 100%, Says Oppenheimer
4/28/202106:08EDGARNotice of Effectiveness (effect)
4/19/202117:18EDGARPost-effective Amendment to Registration Statement (pos Am)
4/19/202117:06EDGARProspectus Filed Pursuant to Rule 424(b)(8) (424b8)
4/14/202106:00GLOBEVascular Biogenics Ltd. Closes Public Offering of Ordinary..
4/12/202109:11EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/09/202109:06SEEKVascular Biogenics prices $25M stock offering
4/09/202108:58GLOBEVascular Biogenics Ltd. Prices Public Offering of Ordinary..
4/09/202106:01EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
4/08/202116:44SEEKVascular Biogenics proposes capital raise
4/08/202116:05GLOBEVascular Biogenics Ltd. Announces Proposed Public Offering..
4/06/202115:34EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/30/202107:00GLOBEVBL Therapeutics to Host Virtual R&D Day on April 6
3/25/202107:10SEEKVBL Therapeutics EPS misses by $0.02, misses on revenue
3/25/202107:01EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
3/25/202107:00GLOBEVBL Therapeutics Reports Fourth Quarter and Full Year 2020..
3/17/202107:00GLOBEVBL Therapeutics to Report Fourth Quarter and Full..
3/08/202107:00GLOBEVBL Therapeutics to Participate at Upcoming Virtual Investor..
3/04/202108:33SEEKVBL Therapeutics' stock up on late-stage VB-111 ovarian..
3/04/202107:00GLOBEVBL Therapeutics Announces Peer-reviewed Publication of..
3/01/202107:00GLOBEVBL Therapeutics Announces Patient Dosing Initiated in..
2/23/202108:18SEEKVET, TCOM, TTM and ZI among premarket gainers
2/22/202107:32SEEKVBL Therapeutics gets green light for VB-111 study in..
2/22/202107:00GLOBEVBL Therapeutics Announces Data Safety Monitoring Committee..
1/27/202107:00GLOBEVBL Therapeutics Treats First Patient in Phase 2 Randomized..
1/15/202107:05EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/15/202107:03EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
1/11/202106:02EDGARNotice of Effectiveness (effect)
12/30/202016:17EDGARSecurities Registration (foreign Private Issuer) (f-3)
11/24/202016:51EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/16/202007:18EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
11/16/202007:03EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/02/202007:00GLOBEVBL Therapeutics to Report Third Quarter 2020 Financial..
10/29/202009:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/19/202016:10EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/13/202008:31EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/15/202008:00GLOBEVBL Therapeutics to Provide an Update on the OVAL Study..
9/11/202008:00GLOBEVBL Presents Human Proof-of-Concept Data That Show the..
8/26/202017:21EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
8/13/202007:01EDGARReport of Foreign Issuer (6-k)
8/13/202007:00GLOBEVBL Therapeutics Announces Second Quarter 2020 Financial..
8/12/202008:46EDGARReport of Foreign Issuer (6-k)
8/05/202016:33EDGARSecurities Registration: Employee Benefit Plan (s-8)
8/03/202008:39EDGARAmended Statement of Ownership (sc 13g/a)
8/03/202008:00GLOBEVBL Therapeutics to Report Second Quarter 2020 Financial..
7/31/202006:29EDGARReport of Foreign Issuer (6-k)
6/22/202008:00GLOBEVBL Therapeutics Presents MOSPD2 Bi-Specific Antibody..
6/04/202007:00GLOBEVBL Presents New Data on the Potential of its Novel..
5/18/202007:00GLOBEVBL Therapeutics to Present New Data on Its MOSPD2..
See more news about this stock »


Your Recent History
NASDAQ
VBLT
Vascular B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.